<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03482544</url>
  </required_header>
  <id_info>
    <org_study_id>KA16/10</org_study_id>
    <nct_id>NCT03482544</nct_id>
  </id_info>
  <brief_title>The Effect of Pregabalin Given Preoperatively on the Tourniquet Induced Ischemia-reperfusion</brief_title>
  <official_title>Effect of Orally Pregabalin Given Before Knee Joint Replacement on Reperfusion Injury Which Caused by Bandage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baskent University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baskent University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The application of tourniquet is indispensable for a bloodless surgical area in total knee
      arthroplasty surgery. The release of tourniquet produces reactive oxygen species which can
      cause injury and then ischemia-reperfusion injury emerge. Our aim in this study is to
      investigate effects of pregabalin, GABA analog drug, on the tourniquet induced
      ischemia-reperfusion injury.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigators will randomize patients into two groups. 1) Pregabalin group 2) Control group.

      Investigators will give orally pregabalin 150 mg to the pregabalin group patients two times
      (first dose 1 day before surgery., second dose 1 hour before surgery). On the other hand
      placebo drug will give to the control group at the same times. Investigators will perform
      combined spinal epidural anesthesia for surgery and inject 3 cc 0.5% hyperbaric bupivacaine
      to subarachnoid space. Investigators will take blood samples for measurement of
      ischemia-reperfusion determinants, immediately before surgery, shortly before tourniquet
      deflation, and 20 minutes after tourniquet deflation. Then these samples will be analysed by
      ELISA method.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 12, 2018</start_date>
  <completion_date type="Anticipated">July 7, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ischemia modified albumin</measure>
    <time_frame>before tournique application,just before tournique release, 20 minutes after tournique release</time_frame>
    <description>changes of ischemia modified albumin</description>
  </primary_outcome>
  <primary_outcome>
    <measure>total oxidant status</measure>
    <time_frame>before tournique application, just before tournique release, 20 minutes after tournique release</time_frame>
    <description>changes of total oxidant status</description>
  </primary_outcome>
  <primary_outcome>
    <measure>total antioxidant status</measure>
    <time_frame>before tournique application, just before tournique release, 20 minutes after tournique release</time_frame>
    <description>changes of total antioxidant status</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>catalase</measure>
    <time_frame>before tournique application, just before tournique release, 20 minutes after tournique release</time_frame>
    <description>changes of catalase</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Ischemia Reperfusion Injury</condition>
  <arm_group>
    <arm_group_label>Pregabalin Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>We will give 150 mg pregabalin capsule orally 1 day before surgery and 1 hour before surgery (totally two times) to the pregabalin group patients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In control group, we will empty the drug material from capsules and give only empty capsules to the control group patients at the same times.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pragabalin</intervention_name>
    <description>pregabalin 150 mg will be given orally, 1 day and 1 hour before surgery (totally two times), patients in Pregabalin Group.</description>
    <arm_group_label>Pregabalin Group</arm_group_label>
    <other_name>pregabalin 150 mg, Lyrica, Pfezir, Almanya</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>empty capsule will be given orally, 1 day and 1 hour before surgery (totally two times), patients in Control Group.</description>
    <arm_group_label>Control Group</arm_group_label>
    <other_name>empty capsule</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. American Society of Anesthesiologists (ASA) physical status I-II

          2. Undergoing a total knee arthroplasty surgery

          3. Accept neuroaxial anesthesia for surgery

        Exclusion Criteria:

          1. Any antiepileptic drug use

          2. Allergic reaction to pregabalin

          3. Severe hepatic, renal or gastrointestinal disorders

          4. Psychiatric disorders

          5. Pregnant women or breastfeeding

          6. NSAID or opioid drug use for a long time

          7. Diabetic or other neuropathic pain
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Omer Karaca, Assist.Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baskent University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Omer Karaca, Dr.</last_name>
    <phone>5301565776</phone>
    <email>dromerkaraca@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Baskent University</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Baskent University</name>
      <address>
        <city>Konya</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Davies SJ, Reichardt-Pascal SY, Vaughan D, Russell GI. Differential effect of ischaemia-reperfusion injury on anti-oxidant enzyme activity in the rat kidney. Exp Nephrol. 1995 Nov-Dec;3(6):348-54.</citation>
    <PMID>8528679</PMID>
  </reference>
  <reference>
    <citation>Vafapour M, Nematbakhsh M, Monajemi R, Mazaheri S, Talebi A, Talebi N, Shirdavani S. Effect of Γ-aminobutyric acid on kidney injury induced by renal ischemia-reperfusion in male and female rats: Gender-related difference. Adv Biomed Res. 2015 Jul 27;4:158. doi: 10.4103/2277-9175.161585. eCollection 2015.</citation>
    <PMID>26380243</PMID>
  </reference>
  <reference>
    <citation>Talebi N, Nematbakhsh M, Monajemi R, Mazaheri S, Talebi A, Vafapour M. The Protective Effect of γ-aminobutyric Acid on Kidney Injury Induced by Renal Ischemia-reperfusion in Ovariectomized Estradiol-treated Rats. Int J Prev Med. 2016 Jan 11;7:6. doi: 10.4103/2008-7802.173796. eCollection 2016.</citation>
    <PMID>26941907</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 5, 2018</study_first_submitted>
  <study_first_submitted_qc>March 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2018</study_first_posted>
  <last_update_submitted>May 10, 2018</last_update_submitted>
  <last_update_submitted_qc>May 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baskent University</investigator_affiliation>
    <investigator_full_name>Omer Karaca</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>pregabalin</keyword>
  <keyword>ischemia reperfusion injury</keyword>
  <keyword>muscle</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Reperfusion Injury</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pregabalin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

